A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)

NCT06281236 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped lack of enrollment

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: Prednisolone
DRUG: SPI-62

Sponsor

Sparrow Pharmaceuticals